Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response

Overview of attention for article published in Frontiers in immunology, March 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 45,255 followers.

RT @FrontImmunol: New Research: Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response: Ionizing ra…

14 Mar 2024

Reply Repost Favourite

La terapia con radionúclidos dirigidos en dosis bajas crea sinergia con las células T con CAR y mejora la respuesta tumoral. https://t.co/zF0QMMcI1w

14 Mar 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response: Ionizing ra…

14 Mar 2024

Reply Repost Favourite

New Research: Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response: Ionizing radiation has garnered considerable attention as a combination partner for immunotherapy due to its potential… https://t.co/NEXaLc60Yt #i

14 Mar 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.